FIELD: medicine; pharmaceuticals.
SUBSTANCE: invention relates to a compound of general formula I, or pharmaceutically acceptable salts thereof, or solvates thereof, in which R1 denotes hydrogen, halogen or nitro; R2 is -NR4R5, where R4 and R5 are independently selected from a group consisting of C1-C6alkyl; or R4, R5 and the nitrogen atom to which they are bonded form saturated 4–6-member heterocyclic ring containing optionally an additional heteroatom, selected from a group consisting of NR6 and O, where the heterocyclic ring is optionally substituted with hydroxyl or C1-C6alkyl, where R6 is C1-C6alkyl; R3 denotes halogen, C1-C6alkoxy or -CORa; Ra is OH or NR7R8, where R7 and R8 are independently selected from a group consisting of hydrogen, C1-C6alkyl optionally substituted with one or more substitutes selected from halogen or NR9R10, and C1-C6alkyl substituted with 3-(C2-C6alkynyl)-3H-diaziridinyl; or R7, R8 and the nitrogen atom to which they are bonded, form 6-member heterocyclic ring containing optionally an additional heteroatom which is N, and optionally substituted with C1-C6alkyl; R9 and R10 are independently selected from a group consisting of C1-C6alkyl; or R9, R10 and the nitrogen atom to which they are bonded, form 5–6 membered heterocyclic ring, containing optionally additional heteroatom, which is O; and X is NH or O attached to the phenyl group by a para- or meta-position. Invention also relates to a pharmaceutical composition, to the use of the compound in the manufacture of a medicinal agent.
EFFECT: obtaining novel compounds of general formula I, which can be used in treating a vimentin mediated disease.
12 cl, 7 dwg, 6 tbl, 9 ex
Title | Year | Author | Number |
---|---|---|---|
PYRROLO[2,1-f][1,2,4]TRIAZINE COMPOUND, METHOD FOR PRODUCTION AND USE THEREOF | 2013 |
|
RU2589053C1 |
HETEROCYCLIC COMPOUND AS PROTEIN KINASE INHIBITOR | 2018 |
|
RU2783723C2 |
COMPOUNDS OF 1-CYANO-PYRROLIDINES AS USP30 INHIBITORS | 2016 |
|
RU2717238C2 |
INHIBITORS OF CDK | 2011 |
|
RU2621674C2 |
KINASE INHIBITORS | 2012 |
|
RU2623734C9 |
FLUORINATED COMPOUND OF CYCLOPROPYLAMINE, THE METHOD OF PREPARATION, THE PHARMACEUTICAL COMPOSITION AND ITS USE | 2017 |
|
RU2746323C2 |
NOVEL PYRAZOLE DERIVATIVES | 2022 |
|
RU2816835C1 |
2-PYRAZINONE DERIVATIVES FOR TREATING DISEASES OR CONDITIONS WHERE INHIBITING NEUTROPHIL ELASTASE ACTIVITY IS USEFUL | 2007 |
|
RU2448098C2 |
AROMATIC 6,7-DISUBSTITUTED 3-QUINOLINECARBOXAMIDE DERIVATIVES, METHOD FOR PRODUCTION THEREOF (VARIANTS), PHARMACEUTICAL COMPOSITION CONTAINING THE SAME AND USE THEREOF IN DRUG MANUFACTURING | 2002 |
|
RU2281940C2 |
2,5-DIOXOIMIDAZOLIN-4-YL METHYLCARBONYL COMPOUNDS, METHOD OF OBTAINING THEM, PHARMACEUTICAL MIXTURES CONTAING THEM AND THIR USE IN MEDICINE PREPARATION | 2003 |
|
RU2326117C2 |
Authors
Dates
2020-11-24—Published
2017-05-11—Filed